Glioblastoma multiforme (GBM) is one of the most devastating tumors affecting more than 5 in 100,000 people. Unfortunately, its diagnosis is often discovered in late stages and is normally deadly, having a life expectancy of 12–15 months and a mere 3% of the affected patients living 3 years or more independent of race, sex, and age. Sadly, current treatments (i.e., chemotherapy, radiation, surgery) are extremely aggressive and extend the patient’s life by little more than a year on average. Even when treatment appears successful, relapse is often experienced. These extreme treatments, combined with their lack of long-term success, call for new innovations. Among them, nanomedicine becomes one of the most promising approaches regarding possible applications in advancing or ameliorating GBM management. In this chapter, we will therefore analyze the state of the art and the most novel and outstanding innovation in terms of diagnosis and treatment options.
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines / Sgarbi, V.; Duskey, J. T.; Ottonelli, I.; Da Ros, F.; Oddone, N.; Vandelli, M. A.; Forni, F.; Tosi, G.; Ruozi, B.. - 163(2021), pp. 1-61.
Data di pubblicazione: | 2021 |
Titolo: | Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines |
Autore/i: | Sgarbi, V.; Duskey, J. T.; Ottonelli, I.; Da Ros, F.; Oddone, N.; Vandelli, M. A.; Forni, F.; Tosi, G.; Ruozi, B. |
Autore/i UNIMORE: | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/978-1-0716-1052-7_1 |
Codice identificativo Scopus: | 2-s2.0-85097178827 |
Serie: | NEUROMETHODS |
Titolo del libro: | Neuromethods |
ISBN: | 978-1-0716-1051-0 978-1-0716-1052-7 |
Editore: | Humana Press Inc. |
Citazione: | Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines / Sgarbi, V.; Duskey, J. T.; Ottonelli, I.; Da Ros, F.; Oddone, N.; Vandelli, M. A.; Forni, F.; Tosi, G.; Ruozi, B.. - 163(2021), pp. 1-61. |
Tipologia | Capitolo/Saggio |
File in questo prodotto:

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris